The product name “Oxapex” is insufficient to identify a confirmed pharmaceutical ingredient. Its active substance should be established from the manufacturer’s label rather than inferred from the name.

Sixpex and a 25 mg strength are provided. The dosage form, active ingredient, excipients, package quantity, and regulatory authorization remain unverified.

GORoids should verify the product documentation before publishing therapeutic, pharmacological, or regulatory claims.